Tag: Lymphoma
Search News
Investigating new treatment targets for lymphoma, and beyond
5th May 2022
We spoke with Dr John Riches, Clinical Senior Lecturer in the Centre for Haemato-Oncology at Barts Cancer Institute, Queen Mary University of London, about his team’s recent publication, which describes a new potential treatment target for a subset of lymphomas.
Read more
Barts Cancer Institute at ASH 2021
17th December 2021
In December each year, the American Society of Hematology (ASH) hosts its Annual Meeting and Exposition – the premier event in malignant and non-malignant haematology. The event represents an invaluable opportunity for researchers at Barts Cancer Institute, Queen Mary University of London to highlight their blood cancer research on an international stage.
Read more
International collaboration set to investigate new treatment strategy for lymphoma
24th November 2021
An international collaboration involving researchers from Queen Mary University of London, Memorial Sloan Kettering Cancer Center, New York and Dana-Farber Cancer Institute, Boston has secured a €1M research grant from Dutch blood cancer charity, Lymph&Co, to investigate a new treatment target for lymphoma.
Read more
Tackling blood cancer with Blood Cancer UK
10th September 2021
This Blood Cancer Awareness Month, find out about the Blood Cancer UK-funded research projects currently underway at the Barts Cancer Institute, which span from looking at the specific genetic changes that drive blood cancer development, to identifying new treatment strategies to improve the outcomes for patients.
Read more
Lymphomas: Perspectives from bench and bedside
15th October 2019
We recently spoke with Dr Jessica Okosun about her work as a clinical researcher working on lymphoma. Find out about her motivations for becoming a clinical researcher and her work on blood cancers.
Read more